Pharmaco-economic inequalities in access to antifibrotic treatment for interstitial lung disease in the Asia-pacific region
Antifibrotic drugs, available for the best part of the last decade in many parts of the world, have improved outcomes in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. However, it is unclear whether patients suffering from these devastating conditions have timely and...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
National Library of Medicine
2025
|
| Subjects: | |
| Online Access: | https://eprints.ums.edu.my/id/eprint/45515/1/FULLTEXT.pdf https://eprints.ums.edu.my/id/eprint/45515/ https://doi.org/10.4046/trd.2025.0056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!
